{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:25:10Z","timestamp":1793118310472,"version":"4.5.0"},"reference-count":137,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2021,7,23]],"date-time":"2021-07-23T00:00:00Z","timestamp":1626998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PRIN 2017","award":["code 2017PPS2X4"],"award-info":[{"award-number":["code 2017PPS2X4"]}]},{"name":"Sergio Luciani Association, Fabriano, Italy","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"Associazione \u201cDaniele Chianelli\u201d","award":["001"],"award-info":[{"award-number":["001"]}]},{"name":"Roche per la Medicina di Precisione, bando 2020","award":["001"],"award-info":[{"award-number":["001"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>T-cell acute lymphoblastic leukemias (T-ALL) are immature lymphoid tumors localizing in the bone marrow, mediastinum, central nervous system, and lymphoid organs. They account for 10\u201315% of pediatric and about 25% of adult acute lymphoblastic leukemia (ALL) cases. It is a widely heterogeneous disease that is caused by the co-occurrence of multiple genetic abnormalities, which are acquired over time, and once accumulated, lead to full-blown leukemia. Recurrently affected genes deregulate pivotal cell processes, such as cycling (CDKN1B, RB1, TP53), signaling transduction (RAS pathway, IL7R\/JAK\/STAT, PI3K\/AKT), epigenetics (PRC2 members, PHF6), and protein translation (RPL10, CNOT3). A remarkable role is played by NOTCH1 and CDKN2A, as they are altered in more than half of the cases. The activation of the NOTCH1 signaling affects thymocyte specification and development, while CDKN2A haploinsufficiency\/inactivation, promotes cell cycle progression. Among recurrently involved oncogenes, a major role is exerted by T-cell-specific transcription factors, whose deregulated expression interferes with normal thymocyte development and causes a stage-specific differentiation arrest. Hence, TAL and\/or LMO deregulation is typical of T-ALL with a mature phenotype (sCD3 positive) that of TLX1, NKX2-1, or TLX3, of cortical T-ALL (CD1a positive); HOXA and MEF2C are instead over-expressed in subsets of Early T-cell Precursor (ETP; immature phenotype) and early T-ALL. Among immature T-ALL, genomic alterations, that cause BCL11B transcriptional deregulation, identify a specific genetic subgroup. Although comprehensive cytogenetic and molecular studies have shed light on the genetic background of T-ALL, biomarkers are not currently adopted in the diagnostic workup of T-ALL, and only a limited number of studies have assessed their clinical implications. In this review, we will focus on recurrent T-ALL abnormalities that define specific leukemogenic pathways and on oncogenes\/oncosuppressors that can serve as diagnostic biomarkers. Moreover, we will discuss how the complex genomic profile of T-ALL can be used to address and test innovative\/targeted therapeutic options.<\/jats:p>","DOI":"10.3390\/genes12081118","type":"journal-article","created":{"date-parts":[[2021,7,25]],"date-time":"2021-07-25T22:06:21Z","timestamp":1627250781000},"page":"1118","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["T-Cell Acute Lymphoblastic Leukemia: Biomarkers and Their Clinical Usefulness"],"prefix":"10.3390","volume":"12","author":[{"given":"Valentina","family":"Bardelli","sequence":"first","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Arniani","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pierini","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5558-7967","authenticated-orcid":false,"given":"Danika","family":"Di Giacomo","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5847-057X","authenticated-orcid":false,"given":"Tiziana","family":"Pierini","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gorello","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy"},{"name":"Department of Chemistry, Biology and Biotechnology, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mecucci","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5854-9846","authenticated-orcid":false,"given":"Roberta","family":"La Starza","sequence":"additional","affiliation":[{"name":"Hematology and Bone Marrow Transplantation Unit, Laboratory of Molecular Medicine (CREO), Department of Medicine and Surgery, University of Perugia, 06132 Perugia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1200\/JCO.2017.77.3648","article-title":"New Approaches to the Management of Adult Acute Lymphoblastic Leukemia","volume":"36","author":"Bassan","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2014-01-547695","article-title":"Oncogenetics and Minimal Residual Disease Are Independent Outcome Predictors in Adult Patients with Acute Lymphoblastic Leukemia","volume":"123","author":"Beldjord","year":"2014","journal-title":"Blood"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1182\/blood-2017-04-778829","article-title":"Oncogenetic Mutations Combined with MRD Improve Outcome Prediction in Pediatric T-Cell Acute Lymphoblastic Leukemia","volume":"131","author":"Petit","year":"2018","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2141.2008.07314.x","article-title":"Molecular-Genetic Insights in Paediatric T-Cell Acute Lymphoblastic Leukaemia","volume":"143","author":"Pieters","year":"2008","journal-title":"Br. J. Haematol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1535-6108(02)00018-1","article-title":"Gene Expression Signatures Define Novel Oncogenic Pathways in T Cell Acute Lymphoblastic Leukemia","volume":"1","author":"Ferrando","year":"2002","journal-title":"Cancer Cell"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1182\/blood-2004-10-3900","article-title":"HOXA Genes are Included in Genetic and Biologic Networks Defining Human Acute T-Cell Leukemia (T-ALL)","volume":"106","author":"Soulier","year":"2005","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ccr.2011.02.008","article-title":"Integrated Transcript and Genome Analyses Reveal NKX2-1 and MEF2C as Potential Oncogenes in T Cell Acute Lymphoblastic Leukemia","volume":"19","author":"Homminga","year":"2011","journal-title":"Cancer Cell"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jmoldx.2020.02.004","article-title":"Design of a Comprehensive Fluorescence in Situ Hybridization Assay for Genetic Classification of T-Cell Acute Lymphoblastic Leukemia","volume":"22","author":"Pierini","year":"2020","journal-title":"J. Mol. Diagn."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The Genomic Landscape of Pediatric and Young Adult T-Lineage Acute Lymphoblastic Leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Di Giacomo, D., La Starza, R., Gorello, P., Pellanera, F., Kalender Atak, Z., De Keersmaecker, K., Pierini, V., Harrison, C.J., Arniani, S., and Moretti, M. (2021). 14q32 Rearrangements Deregulating BCL11B Mark a Distinct Subgroup of T and Myeloid Immature Acute Leukemia. Blood, in press.","DOI":"10.1182\/blood.2020010510"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1126\/science.1259037","article-title":"An Oncogenic Super-Enhancer Formed through Somatic Mutation of a Noncoding Intergenic Element","volume":"346","author":"Mansour","year":"2014","journal-title":"Science"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1038\/leu.2017.75","article-title":"APOBEC Signature Mutation Generates an Oncogenic Enhancer That Drives LMO1 Expression in T-ALL","volume":"31","author":"Li","year":"2017","journal-title":"Leukemia"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.1182\/blood-2016-09-742148","article-title":"Activation of the LMO2 Oncogene through a Somatically Acquired Neomorphic Promoter in T-Cell Acute Lymphoblastic Leukemia","volume":"129","author":"Rahman","year":"2017","journal-title":"Blood"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1093\/emboj\/16.9.2408","article-title":"An Scl Gene Product Lacking the Transactivation Domain Induces Bony Abnormalities and Cooperates with LMO1 to Generate T-Cell Malignancies in Transgenic Mice","volume":"16","author":"Aplan","year":"1997","journal-title":"EMBO J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1101\/gad.1897910","article-title":"Modeling T-Cell Acute Lymphoblastic Leukemia Induced by the SCL and LMO1 Oncogenes","volume":"24","author":"Tremblay","year":"2010","journal-title":"Genes Dev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1084\/jem.20100745","article-title":"NKX3.1 Is a Direct TAL1 Target Gene That Mediates Proliferation of TAL1-Expressing Human T Cell Acute Lymphoblastic Leukemia","volume":"207","author":"Kusy","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ccr.2012.06.007","article-title":"Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic Leukemia","volume":"22","author":"Sanda","year":"2012","journal-title":"Cancer Cell"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.1182\/blood-2014-06-578856","article-title":"Genetic Profile of T-Cell Acute Lymphoblastic Leukemias with MYC Translocations","volume":"124","author":"Borga","year":"2014","journal-title":"Blood"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/bjh.15425","article-title":"Genetic Characterization and Therapeutic Targeting of MYC -rearranged T Cell Acute Lymphoblastic Leukaemia","volume":"185","author":"Milani","year":"2019","journal-title":"Br. J. Haematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1038\/bcj.2013.72","article-title":"Highly Aggressive T-Cell Acute Lymphoblastic Leukemia with t(8;14)(Q24;Q11): Extensive Genetic Characterization and Achievement of Early Molecular Remission and Long-Term Survival in an Adult Patient","volume":"4","author":"Parolini","year":"2014","journal-title":"Blood Cancer J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1182\/blood-2008-10-186536","article-title":"High-Resolution Genomic Profiling of Childhood T-ALL Reveals Frequent Copy-Number Alterations Affecting the TGF-\u03b2 and PI3K-AKT Pathways and Deletions at 6q15-16.1 as a Genomic Marker for Unfavorable Early Treatment Response","volume":"114","author":"Remke","year":"2009","journal-title":"Blood"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1158\/2159-8290.CD-17-0831","article-title":"Deletion 6q Drives T-Cell Leukemia Progression by Ribosome Modulation","volume":"8","author":"Gachet","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_23","first-page":"1783","article-title":"Proposals for the Immunological Classification of Acute Leukemias. European Group for the Immunological Characterization of Leukemias (EGIL)","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1470-2045(08)70314-0","article-title":"Early T-Cell Precursor Leukaemia: A Subtype of Very High-Risk Acute Lymphoblastic Leukaemia","volume":"10","author":"Mullighan","year":"2009","journal-title":"Lancet Oncol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1158\/2159-8290.CD-14-0353","article-title":"Maturation Stage of T-Cell Acute Lymphoblastic Leukemia Determines BCL-2 versus BCL-XL Dependence and Sensitivity to ABT-199","volume":"4","author":"Roderick","year":"2014","journal-title":"Cancer Discov."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"3738-3738","DOI":"10.1182\/blood-2014-05-574566","article-title":"ABT-199 Mediated Inhibition of BCL-2 as a Novel Therapeutic Strategy in T-Cell Acute Lymphoblastic Leukemia","volume":"124","author":"Peirs","year":"2014","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"La Starza, R., Camb\u00f2, B., Pierini, A., Bornhauser, B., Montanaro, A., Bourquin, J.-P., Mecucci, C., and Roti, G. (2019). Venetoclax and Bortezomib in Relapsed\/Refractory Early T-Cell Precursor Acute Lymphoblastic Leukemia. JCO Precis. Oncol., 3.","DOI":"10.1200\/PO.19.00172"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/nature10745","article-title":"The Genetic Basis of Early T-Cell Precursor Acute Lymphoblastic Leukaemia","volume":"481","author":"Zhang","year":"2012","journal-title":"Nature"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1038\/bcj.2011.49","article-title":"Clinical and Molecular Characterization of Early T-Cell Precursor Leukemia: A High-Risk Subgroup in Adult T-ALL with a High Frequency of FLT3 Mutations","volume":"2","author":"Neumann","year":"2012","journal-title":"Blood Cancer J."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1182\/blood-2013-02-487256","article-title":"New MLLT10 Gene Recombinations in Pediatric T-Acute Lymphoblastic Leukemia","volume":"121","author":"Brandimarte","year":"2013","journal-title":"Blood"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3324\/haematol.2013.101725","article-title":"DDX3X-MLLT10 Fusion in Adults with NOTCH1 Positive T-Cell Acute Lymphoblastic Leukemia","volume":"99","author":"Brandimarte","year":"2014","journal-title":"Haematologica"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4668","DOI":"10.1182\/blood-2007-09-111872","article-title":"The Recurrent SET-NUP214 Fusion as a New HOXA Activation Mechanism in Pediatric T-Cell Acute Lymphoblastic Leukemia","volume":"111","author":"Tchinda","year":"2008","journal-title":"Blood"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3324\/haematol.2009.010413","article-title":"Combined Interphase Fluorescence in Situ Hybridization Elucidates the Genetic Heterogeneity of T-Cell Acute Lymphoblastic Leukemia in Adults","volume":"95","author":"Gorello","year":"2010","journal-title":"Haematologica"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1073\/pnas.1717125115","article-title":"Identification of Fusion Genes and Characterization of Transcriptome Features in T-Cell Acute Lymphoblastic Leukemia","volume":"115","author":"Chen","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1038\/sj.leu.2404187","article-title":"HOXA Cluster Deregulation in T-ALL Associated with Both a TCRD-HOXA and a CALM-AF10 Chromosomal Translocation","volume":"20","author":"Bergeron","year":"2006","journal-title":"Leukemia"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3324\/haematol.2015.141218","article-title":"An Early Thymic Precursor Phenotype Predicts Outcome Exclusively in HOXA-Overexpressing Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia Study","volume":"101","author":"Bond","year":"2016","journal-title":"Haematologica"},{"key":"ref_37","first-page":"1212","article-title":"The Outcome of Molecular-Cytogenetic Subgroups in Pediatric T-Cell Acute Lymphoblastic Leukemia: A Retrospective Study of Patients Treated According to DCOG or COALL Protocols","volume":"91","author":"Meijerink","year":"2006","journal-title":"Haematologica"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.3324\/haematol.2013.086082","article-title":"The Prognosis of CALM-AF10-Positive Adult T-Cell Acute Lymphoblastic Leukemias Depends on the Stage of Maturation Arrest","volume":"98","author":"Asnafi","year":"2013","journal-title":"Haematologica"},{"key":"ref_39","first-page":"61","article-title":"Brief Report LYMPHOID NEOPLASIA SET-NUP214 Is a Recurrent Gd Lineage-Specific Fusion Transcript Associated with Corticosteroid\/Chemotherapy Resistance in Adult T-ALL","volume":"123","author":"Abdelali","year":"2014","journal-title":"Blood J. Am. Soc. Hematol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1038\/leu.2016.60","article-title":"MLL Rearrangements Impact Outcome in HOXA-Deregulated T-Lineage Acute Lymphoblastic Leukemia: A Children\u2019s Oncology Group Study","volume":"30","author":"Kang","year":"2016","journal-title":"Leukemia"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3324\/haematol.2013.090233","article-title":"Immature MEF2C-Dysregulated T-Cell Leukemia Patients Have an Early T-Cell Precursor Acute Lymphoblastic Leukemia Gene Signature and Typically Have Non-Rearranged t-Cell Receptors","volume":"99","author":"Zuurbier","year":"2014","journal-title":"Haematologica"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1080\/10428194.2017.1312383","article-title":"MEF2C-Dysregulated Pediatric T-Cell Acute Lymphoblastic Leukemia Is Associated with CDKN1B Deletions and a Poor Response to Glucocorticoid Therapy","volume":"58","author":"Pisecker","year":"2017","journal-title":"Leuk. Lymphoma"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Montefiori, L.E., Bendig, S., Gu, Z., Chen, X., Polonen, P., Ma, X., Murison, A., Zeng, A., Garcia-Prat, L., and Dickerson, K. (2021). Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage Ambiguous Stem Cell Leukemia. Cancer Discov.","DOI":"10.1158\/2159-8290.CD-21-0145"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/nm.2246","article-title":"The TLX1 Oncogene Drives Aneuploidy in T Cell Transformation","volume":"16","author":"Real","year":"2010","journal-title":"Nat. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ng.2508","article-title":"Exome Sequencing Identifies Mutation in CNOT3 and Ribosomal Genes RPL5 and RPL10 in T-Cell Acute Lymphoblastic Leukemia","volume":"45","author":"Atak","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1182\/blood-2010-02-269878","article-title":"LEF-1 Is a Prosurvival Factor in Chronic Lymphocytic Leukemia and Is Expressed in the Preleukemic State of Monoclonal B-Cell Lymphocytosis","volume":"116","author":"Gutierrez","year":"2010","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0140-6736(04)15542-6","article-title":"Prognostic Importance of TLX1 (HOX11) Oncogene Expression in Adults with T-Cell Acute Lymphoblastic Leukaemia","volume":"363","author":"Ferrando","year":"2004","journal-title":"Lancet"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1182\/blood-2007-04-079988","article-title":"Prognostic and Oncogenic Relevance of TLX1\/HOX11 Expression Level in T-ALLs","volume":"110","author":"Bergeron","year":"2007","journal-title":"Blood"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.3324\/haematol.13291","article-title":"Impact of Genotype on Survival of Children with T-Cell Acute Lymphoblastic Leukemia Treated According to the French Protocol FRALLE-93: The Effect of TLX3\/HOX11L2 Gene Expression on Outcome","volume":"93","author":"Ballerini","year":"2008","journal-title":"Haematologica"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"100647","DOI":"10.1016\/j.jbior.2019.100647","article-title":"Multi-Omic Approaches to Improve Outcome for T-Cell Acute Lymphoblastic Leukemia Patients","volume":"74","author":"Cordo","year":"2019","journal-title":"Adv. Biol. Regul."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1038\/sj.leu.2402671","article-title":"Disruption of the RanBP17\/Hox11L2 Region by Recombination with the TCR\u03b4 Locus in Acute Lymphoblastic Leukemias with t(5;14)(Q34;Q11)","volume":"16","author":"Kiyoi","year":"2002","journal-title":"Leukemia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1182\/blood-2001-11-0093","article-title":"HOX11L2 Expression Defines a Clinical Subtype of Pediatric T-ALL Associated with Poor Prognosis","volume":"100","author":"Ballerini","year":"2002","journal-title":"Blood"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/leu.2008.52","article-title":"Thymic Adult T-Cell Acute Lymphoblastic Leukemia Stratified in Standard- and High-Risk Group by Aberrant HOX11L2 Expression: Experience of the German Multicenter ALL Study Group","volume":"22","author":"Baak","year":"2008","journal-title":"Leukemia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1182\/blood-2003-05-1495","article-title":"Clinical Significance of HOX11L2 Expression Linked to t(5;14)(Q35;Q32), of HOX11 Expression, and of SIL-TAL Fusion in Childhood T-Cell Malignancies: Results of EORTC Studies 58881 and 58951","volume":"103","author":"Suciu","year":"2004","journal-title":"Blood"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.leu.2403834","article-title":"Significance of HOX11L2\/TLX3 Expression in Children with T-Cell Acute Lymphoblastic Leukemia Treated on Children\u2019s Cancer Group Protocols","volume":"19","author":"Gottardo","year":"2005","journal-title":"Leukemia"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1172\/JCI92981","article-title":"The NOTCH1\/CD44 Axis Drives Pathogenesis in a T Cell Acute Lymphoblastic Leukemia Model","volume":"128","author":"Fuentes","year":"2018","journal-title":"J. Clin. Investig."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","article-title":"Notch 1 Activation in the Molecular Pathogenesis of T-Cell Acute Lymphoblastic Leukaemia","volume":"6","author":"Grabher","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.leu.2402884","article-title":"Molecular Cytogenetic Detection of Chromosomal Breakpoints in T-Cell Receptor Gene Loci","volume":"17","author":"Gesk","year":"2003","journal-title":"Leukemia"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/leu.2008.366","article-title":"A Second NOTCH1 Chromosome Rearrangement: T(9;14)(Q34.3;Q11.2) in T-Cell Neoplasia","volume":"23","author":"Suzuki","year":"2009","journal-title":"Leukemia"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 Mutations in Leukemic Cells Mediate NOTCH Pathway Activation and Resistance to \u03b3-Secretase Inhibitors","volume":"204","author":"Grim","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1084\/jem.20070872","article-title":"The SCFFBW7 Ubiquitin Ligase Complex as a Tumor Suppressor in T Cell Leukemia","volume":"204","author":"Thompson","year":"2007","journal-title":"J. Exp. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/2040620712471368","article-title":"The NOTCH Signaling Pathway: Role in the Pathogenesis of T-Cell Acute Lymphoblastic Leukemia and Implication for Therapy","volume":"4","author":"Tosello","year":"2013","journal-title":"Ther. Adv. Hematol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"4352","DOI":"10.1200\/JCO.2009.22.0996","article-title":"Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults with T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII\/ECOG E2993 Protocol","volume":"27","author":"Mansour","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1038\/leu.2010.205","article-title":"NOTCH1 and FBXW7 Mutations Have a Favorable Impact on Early Response to Treatment, but Not on Outcome, in Children with T-Cell Acute Lymphoblastic Leukemia (T-ALL) Treated on EORTC Trials 58881 and 58951","volume":"24","author":"Clappier","year":"2010","journal-title":"Leukemia"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1038\/leu.2010.204","article-title":"NOTCH1 and\/or FBXW7 Mutations Predict for Initial Good Prednisone Response but Not for Improved Outcome in Pediatric T-Cell Acute Lymphoblastic Leukemia Patients Treated on DCOG or COALL Protocols","volume":"24","author":"Zuurbier","year":"2010","journal-title":"Leukemia"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1200\/JCO.2011.39.7661","article-title":"Clinical Impact of NOTCH1 and\/or FBXW7 Mutations, FLASH Deletion, and TCR Status in Pediatric T-Cell Lymphoblastic Lymphoma","volume":"30","author":"Callens","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40164-020-00187-x","article-title":"Advances of Target Therapy on NOTCH1 Signaling Pathway in T-Cell Acute Lymphoblastic Leukemia","volume":"9","author":"Zheng","year":"2020","journal-title":"Exp. Hematol. Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1038\/s41375-019-0653-z","article-title":"Therapeutic Targeting of the E3 Ubiquitin Ligase SKP2 in T-ALL","volume":"34","author":"Rodriguez","year":"2020","journal-title":"Leukemia"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.chembiol.2020.04.002","article-title":"Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic Leukemia","volume":"27","author":"Marchesini","year":"2020","journal-title":"Cell Chem. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1182\/blood-2007-02-074690","article-title":"NOTCH1 Mutation Can Be an Early, Prenatal Genetic Event in T-ALL","volume":"111","author":"Eguchi","year":"2008","journal-title":"Blood"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive Development of T Cell Neoplasms in Mice Transplanted with Bone Marrow Expressing Activated Notch Alleles","volume":"183","author":"Pear","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2005-06-2553","article-title":"Activating Notch1 Mutations in Mouse Models of T-ALL","volume":"107","author":"Calvo","year":"2006","journal-title":"Blood"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1182\/blood-2005-07-3013","article-title":"Notch1 Mutations Are Important for Leukemic Transformation in Murine Models of Precursor-T Leukemia\/Lymphoma","volume":"107","author":"Lin","year":"2006","journal-title":"Blood"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1182\/blood.2020006996","article-title":"Single-Cell DNA Amplicon Sequencing Reveals Clonal Heterogeneity and Evolution in T-Cell Acute Lymphoblastic Leukemia","volume":"137","author":"Demeyer","year":"2021","journal-title":"Blood"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1158\/1078-0432.CCR-07-1474","article-title":"Notch-1 Mutations Are Secondary Events in Some Patients with T-Cell Acute Lymphoblastic Leukemia","volume":"13","author":"Mansour","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nri2023","article-title":"Interleukin-7 Receptor Expression: Intelligent Design","volume":"7","author":"Mazzucchelli","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/onc.2012.347","article-title":"JAK\/STAT Signaling in Hematological Malignancies","volume":"32","author":"Vainchenker","year":"2013","journal-title":"Oncogene"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/ng.924","article-title":"Oncogenic IL7R Gain-of-Function Mutations in Childhood T-Cell Acute Lymphoblastic Leukemia","volume":"43","author":"Zenatti","year":"2011","journal-title":"Nat. Genet."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/leu.2016.100","article-title":"Loss-of-Function Mutations of Dynamin 2 Promote T-ALL by Enhancing IL-7 Signalling","volume":"30","author":"Tremblay","year":"2016","journal-title":"Leukemia"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nrc.2016.63","article-title":"The Genetics and Mechanisms of T Cell Acute Lymphoblastic Leukaemia","volume":"16","author":"Belver","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.3324\/haematol.2011.041921","article-title":"Mutation Analysis of the Tyrosine Phosphatase PTPN2 in Hodgkin\u2019s Lymphoma and T-Cell Non-Hodgkin\u2019s Lymphoma","volume":"96","author":"Kleppe","year":"2011","journal-title":"Haematologica"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.3324\/haematol.2015.130179","article-title":"Targeted Sequencing Identifies Associations between IL7R-JAK Mutations and Epigenetic Modulators in T-Cell Acute Lymphoblastic Leukemia","volume":"100","author":"Vicente","year":"2015","journal-title":"Haematologica"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1038\/leu.2014.89","article-title":"Novel Activating STAT5B Mutations as Putative Drivers of T-Cell Acute Lymphoblastic Leukemia","volume":"28","author":"Kontro","year":"2014","journal-title":"Leukemia"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1182\/blood-2014-06-580480","article-title":"Efficacy of JAK\/STAT Pathway Inhibition in Murine Xenograft Models of Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia","volume":"125","author":"Maude","year":"2015","journal-title":"Blood"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/leu.2017.136","article-title":"JAK\/STAT Pathway Inhibition Overcomes IL7-Induced Glucocorticoid Resistance in a Subset of Human T-Cell Acute Lymphoblastic Leukemias","volume":"31","author":"Meyer","year":"2017","journal-title":"Leukemia"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1038\/s41375-018-0031-2","article-title":"High PIM1 Expression Is a Biomarker of T-Cell Acute Lymphoblastic Leukemia with JAK\/STAT Activation or t(6;7)(P21;Q34)\/TRB@-PIM1 Rearrangement","volume":"32","author":"Messina","year":"2018","journal-title":"Leukemia"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.3324\/haematol.2018.199257","article-title":"Pre-Clinical Evaluation of Second Generation PIM Inhibitors for the Treatment of T-Cell Acute Lymphoblastic Leukemia and Lymphoma","volume":"104","author":"Peirs","year":"2019","journal-title":"Haematologica"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"30199","DOI":"10.18632\/oncotarget.16320","article-title":"Targeting the PIM Protein Kinases for the Treatment of a T-Cell Acute Lymphoblastic Leukemia Subset","volume":"8","author":"Padi","year":"2017","journal-title":"Oncotarget"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1182\/blood.2019003880","article-title":"Targeting Cytokine\u2013and Therapy-Induced PIM1 Activation in Preclinical Models of T-Cell Acute Lymphoblastic Leukemia and Lymphoma","volume":"135","author":"Morscio","year":"2020","journal-title":"Blood"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/ng1425","article-title":"Fusion of NUP214 to ABL1 on Amplified Episomes in T-Cell Acute Lymphoblastic Leukemia","volume":"36","author":"Graux","year":"2004","journal-title":"Nat. Genet."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1002\/gcc.20743","article-title":"ABL1 Rearrangements in T-Cell Acute Lymphoblastic Leukemia","volume":"49","author":"Hagemeijer","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1182\/blood-2004-12-4897","article-title":"Fusion of EML1 to ABL1 in T-Cell Acute Lymphoblastic Leukemia with Cryptic t(9;14)(Q34;Q32)","volume":"105","author":"Graux","year":"2005","journal-title":"Blood"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/bjh.17093","article-title":"Adjuvant Tyrosine Kinase Inhibitor Therapy Improves Outcome for Children and Adolescents with Acute Lymphoblastic Leukaemia Who Have an ABL-Class Fusion","volume":"191","author":"Moorman","year":"2020","journal-title":"Br. J. Haematol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3324\/haematol.2013.088674","article-title":"NUP214-ABL1-Mediated Cell Proliferation in T-Cell Acute Lymphoblastic Leukemia Is Dependent on the LCK Kinase and Various Interacting Proteins","volume":"99","author":"Porcu","year":"2014","journal-title":"Haematologica"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/leu.2008.80","article-title":"Activity of Tyrosine Kinase Inhibitors against Human NUP214-ABL1-Positive T Cell Malignancies","volume":"22","author":"Tong","year":"2008","journal-title":"Leukemia"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/leu.2017.13","article-title":"Phosphoproteomic Analysis Reveals Hyperactivation of MTOR\/STAT3 and LCK\/Calcineurin Axes in Pediatric Early T-Cell Precursor ALL","volume":"31","author":"Serafin","year":"2017","journal-title":"Leukemia"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1182\/blood-2017-05-784603","article-title":"Glucocorticoid Resistance Is Reverted by LCK Inhibition in Pediatric T-Cell Acute Lymphoblastic Leukemia","volume":"130","author":"Serafin","year":"2017","journal-title":"Blood"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1182\/blood-2016-09-738070","article-title":"Ex Vivo Drug Response Profiling Detects Recurrent Sensitivity Patterns in Drug-Resistant Acute Lymphoblastic Leukemia","volume":"129","author":"Frismantas","year":"2017","journal-title":"Blood"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-Wide Analysis of Genetic Alterations in Acute Lymphoblastic Leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational Loss of PTEN Induces Resistance to NOTCH1 Inhibition in T-Cell Leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat. Med."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1158\/2643-3230.BCD-20-0201","article-title":"A Tumor Suppressor Enhancer of PTEN in T-Cell Development and Leukemia","volume":"2","author":"Tottone","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"4169","DOI":"10.1182\/blood-2010-11-318873","article-title":"The BCL11B Tumor Suppressor Is Mutated across the Major Molecular Subtypes of T-Cell Acute Lymphoblastic Leukemia","volume":"118","author":"Gutierrez","year":"2011","journal-title":"Blood"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2012.48.5292","article-title":"Toward a NOTCH1\/FBXW7\/RAS\/PTEN-Based Oncogenetic Risk Classification of Adult T-Cell Acute Lymphoblastic Leukemia: A Group for Research in Adult Acute Lymphoblastic Leukemia Study","volume":"31","author":"Trinquand","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1182\/blood-2009-02-206722","article-title":"High Frequency of PTEN, PI3K, and AKT Abnormalities in T-Cell Acute Lymphoblastic Leukemia","volume":"114","author":"Gutierrez","year":"2009","journal-title":"Blood"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1038\/leu.2017.157","article-title":"Age-Related Clinical and Biological Features of PTEN Abnormalities in T-Cell Acute Lymphoblastic Leukaemia","volume":"31","author":"Tesio","year":"2017","journal-title":"Leukemia"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3389\/fimmu.2018.00369","article-title":"Activated PI3 Kinase Delta Syndrome: From Genetics to Therapy","volume":"9","author":"Michalovich","year":"2018","journal-title":"Front. Immunol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"E335","DOI":"10.1002\/ajh.25998","article-title":"A Novel Germline Variant in PIK3R1 Results in SHORT Syndrome Associated with TAL\/LMO T-cell Acute Lymphoblastic Leukemia","volume":"95","author":"Marzollo","year":"2020","journal-title":"Am. J. Hematol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"13105","DOI":"10.18632\/oncotarget.3524","article-title":"PI3K Inhibition Synergizes with Glucocorticoids but Antagonizes with Methotrexate in T-Cell Acute Lymphoblastic Leukemia","volume":"6","author":"Silveira","year":"2015","journal-title":"Oncotarget"},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Follini, E., Marchesini, M., and Roti, G. (2019). Strategies to Overcome Resistance Mechanisms in T-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20123021"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2014-04-531871","article-title":"Ras Pathway Mutations Are Prevalent in Relapsed Childhood Acute Lymphoblastic Leukemia and Confer Sensitivity to MEK Inhibition","volume":"124","author":"Irving","year":"2014","journal-title":"Blood"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"11306","DOI":"10.1073\/pnas.1608420113","article-title":"Mutational Landscape, Clonal Evolution Patterns, and Role of RAS Mutations in Relapsed Acute Lymphoblastic Leukemia","volume":"113","author":"Oshima","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"100591","DOI":"10.1016\/j.blre.2019.100591","article-title":"Targeting Steroid Resistance in T-Cell Acute Lymphoblastic Leukemia","volume":"38","author":"Morscio","year":"2019","journal-title":"Blood Rev."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1182\/blood-2007-06-095075","article-title":"Leukemia-Associated NF1 Inactivation in Patients with Pediatric T-ALL and AML Lacking Evidence for Neurofibromatosis","volume":"111","author":"Balgobind","year":"2008","journal-title":"Blood"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3324\/haematol.2015.139410","article-title":"RNA Sequencing Unravels the Genetics of Refractory\/Relapsed T-Cell Acute Lymphoblastic Leukemia. Prognostic and Therapeutic Implications","volume":"101","author":"Gianfelici","year":"2016","journal-title":"Haematologica"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"e523","DOI":"10.1038\/bcj.2017.3","article-title":"Identification of a Genetically Defined Ultra-High-Risk Group in Relapsed Pediatric T-Lymphoblastic Leukemia","volume":"7","author":"Kunz","year":"2017","journal-title":"Blood Cancer J."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13045-016-0344-4","article-title":"Improving Nelarabine Efficacy in T Cell Acute Lymphoblastic Leukemia by Targeting Aberrant PI3K\/AKT\/MTOR Signaling Pathway","volume":"9","author":"Lonetti","year":"2016","journal-title":"J. Hematol. Oncol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ng.542","article-title":"PHF6 Mutations in T-Cell Acute Lymphoblastic Leukemia","volume":"42","author":"Palomero","year":"2010","journal-title":"Nature Genet."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.nbd.2016.09.011","article-title":"Pathogenesis of B\u00f6rjeson-Forssman-Lehmann Syndrome: Insights from PHF6 Function","volume":"96","author":"Cheng","year":"2016","journal-title":"Neurobiol. Dis."},{"key":"ref_120","doi-asserted-by":"crossref","unstructured":"Chao, M.M., Todd, M.A., Kontny, U., Neas, K., Sullivan, M.J., Hunter, A.G., Picketts, D.J., and Kratz, C.P. (2010). T-Cell Acute Lymphoblastic Leukemia in Association with B\u00f6rjeson-Forssman-Lehmann Syndrome Due to a Mutation in PHF6. Pediatric Blood Cancer, 55.","DOI":"10.1002\/pbc.22574"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1021\/pr3004369","article-title":"PHF6 Interacts with the Nucleosome Remodeling and Deacetylation (NuRD) Complex","volume":"11","author":"Todd","year":"2012","journal-title":"J. Proteome Res."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1074\/jbc.M112.414839","article-title":"PHF6 Regulates Cell Cycle Progression by Suppressing Ribosomal RNA Synthesis","volume":"288","author":"Wang","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.neuron.2013.04.021","article-title":"The X-Linked Intellectual Disability Protein PHF6 Associates with the PAF1 Complex and Regulates Neuronal Migration in the Mammalian Brain","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/2159-8290.CD-18-1005","article-title":"Phf6 Loss Enhances HSC Self-Renewal Driving Tumor Initiation and Leukemia Stem Cell Activity in T-All","volume":"9","author":"Wendorff","year":"2019","journal-title":"Cancer Discov."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nature13605","article-title":"Contrasting Roles of Histone 3 Lysine 27 Demethylases in Acute Lymphoblastic Leukaemia","volume":"514","author":"Ntziachristos","year":"2014","journal-title":"Nature"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/nature06192","article-title":"A Histone H3 Lysine 27 Demethylase Regulates Animal Posterior Development","volume":"449","author":"Lan","year":"2007","journal-title":"Nature"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1182\/blood-2014-05-577270","article-title":"The H3K27me3 Demethylase UTX Is a Gender-Specific Tumor Suppressor in T-Cell Acute Lymphoblastic Leukemia","volume":"125","author":"Sanghvi","year":"2015","journal-title":"Blood"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1158\/2643-3230.BCD-20-0059","article-title":"Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-Cell Acute Lymphoblastic Leukemia","volume":"1","author":"Roels","year":"2020","journal-title":"Blood Cancer Discov."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1084\/jem.20180570","article-title":"PRC2 Loss Induces Chemoresistance by Repressing Apoptosis in T Cell Acute Lymphoblastic Leukemia","volume":"215","author":"Bodaar","year":"2018","journal-title":"J. Exp. Med."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nm.2651","article-title":"Genetic Inactivation of the Polycomb Repressive Complex 2 in T Cell Acute Lymphoblastic Leukemia","volume":"18","author":"Ntziachristos","year":"2012","journal-title":"Nat. Med."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1182\/blood.2019000015","article-title":"Suz12 Inactivation Cooperates with JAK3 Mutant Signaling in the Development of T-Cell Acute Lymphoblastic Leukemia","volume":"134","author":"Broux","year":"2019","journal-title":"Blood"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/bjh.13613","article-title":"Distinctive Genotypes in Infants with T-Cell Acute Lymphoblastic Leukaemia","volume":"171","author":"Mansur","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/gcc.22423","article-title":"T-Cell Acute Lymphoblastic Leukemia in Infants Has Distinct Genetic and Epigenetic Features Compared to Childhood Cases","volume":"56","author":"Doerrenberg","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood-2006-12-064683","article-title":"The C-MYB Locus Is Involved in Chromosomal Translocation and Genomic Duplications in Human T-Cell Acute Leukemia (T-ALL), the Translocation Defining a New T-ALL Subtype in Very Young Children","volume":"110","author":"Clappier","year":"2007","journal-title":"Blood"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/gcc.22943","article-title":"MYB Rearrangements and Over-expression in T-cell Acute Lymphoblastic Leukemia","volume":"60","author":"Bardelli","year":"2021","journal-title":"Genes Chromosomes Cancer"},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Ramdeny, P.S., Mullanfroze, K., Lorenzo, P., Grazia Valsecchi, M., Meijerink, J., Pieters, R., Baruchel, A., and Vora, A. (2021). Infant T-cell Acute Lymphoblastic Leukaemia with t(6;7)(TCRB-MYB) Translocation. Br. J. Haematol., 17609.","DOI":"10.1111\/bjh.17609"},{"key":"ref_137","doi-asserted-by":"crossref","unstructured":"G\u0119barowska, K., Mroczek, A., Kowalczyk, J.R., and Lejman, M. (2021). MicroRNA as a Prognostic and Diagnostic Marker in T-Cell Acute Lymphoblastic Leukemia. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22105317"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/8\/1118\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:34:13Z","timestamp":1760164453000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/12\/8\/1118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,23]]},"references-count":137,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["genes12081118"],"URL":"https:\/\/doi.org\/10.3390\/genes12081118","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,23]]}}}